EDAP TMS S.A. - AMERIC

EDAP Reports First Quarter 2024 Financial Results

16 May 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

06 May 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

02 May 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

23 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results

27 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

13 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

06 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

04 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

29 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis

01 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements

08 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer

02 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer

12 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors

06 Dec 2023 15:30:00 By Nasdaq GlobeNewswire

EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology

30 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

20 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Third Quarter 2023 Financial Results

09 Nov 2023 05:00:00 By Nasdaq GlobeNewswire

EDAP to Present at the Jefferies London Healthcare Conference

06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023

26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire